ARTL — Artelo Biosciences Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:54 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 09:30 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:59 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:03 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Artelo Biosciences Secures Notice Of Allowance In Japan For Patent Claims For The Intended Commercial Formulation Of Art27.13
Brief: Artelo Biosciences - Receives Uspto Notice Of Allowance For Art27.13 Formulation Patent
Artelo Biosciences Q2 net loss narrows as R&D expenses fall
Brief: Artelo Biosciences To Offer Up To $6.53 Million In Common Stock Via H.C. Wainwright
Brief: Artelo Biosciences To Terminate At-The-Market Offering Agreement Effective May 18, 2026 - SEC Filing
Artelo Biosciences Q1 net loss widens, R&D expenses fall
Brief: Artelo Biosciences May Offer Securities Up To $75 Million - SEC Filing
Brief: Artelo Biosciences Inc Announces Strategic Partnership With Sciencemachine For Fabp5 Inhibitor Development
NASDAQ RESUMED AT 02:01 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:56 PM
NASDAQ RESUMED AT 01:41 PM